A method of treating prostate cancer by intradermally injecting a person with a composition comprising (a) a recall antigen and (b) prostate specific antigen (PSA) or peptides that are fragments of PSA is provided. The recall antigen may be Candida extract, Trichophyton antigens, or mumps antigen, or other recall antigen.
